Search Results - "Venerito, Marino"

Gastric cancer: epidemiology, prevention, and therapy by Venerito, Marino, Vasapolli, Riccardo, Rokkas, Theodoros, Malfertheiner, Peter

“…Gastric cancer (GC) is still the third leading cause of cancer death in both sexes worldwide. Helicobacter pylori infection is the most important risk factor…”
Get full text

Review: Gastric cancer—Clinical aspects by Venerito, Marino, Link, Alexander, Rokkas, Theodoros, Malfertheiner, Peter

“…Gastric cancer (GC) was responsible for over 1 000 000 new cases in 2018 and an estimated 783 000 deaths, making it still the fifth most frequently diagnosed…”
Get full text

Proton-pump inhibitors: understanding the complications and risks by Malfertheiner, Peter, Kandulski, Arne, Venerito, Marino

“…Key Points Proton-pump inhibitors (PPIs) induce structural and functional changes in the gastric mucosa related to potent acid suppression, which are…”
Get full text

S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study by Venerito, Marino

“…Background and Objectives S-1-based regimens have been shown to be as effective as other fluoropyrimidine-based regimens with a better safety profile in…”
Get full text

Review: Prevention and management of gastric cancer by Venerito, Marino, Ford, Alexander C., Rokkas, Theodoros, Malfertheiner, Peter

“…Gastric cancer (GC) is still the fifth most frequently diagnosed cancer and the third leading cause of cancer deaths in both sexes worldwide. Although the…”
Get full text

Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection by Venerito, Marino, Krieger, Tina, Ecker, Thomas, Leandro, Gioacchino, Malfertheiner, Peter

“…In areas with high clarithromycin resistance, bismuth quadruple therapy (BQT) is recommended instead of clarithromycin triple therapy (CTT) as the first-line…”
Get more information

Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers by Himmelsbach, Vera, Pinter, Matthias, Scheiner, Bernhard, Venerito, Marino, Sinner, Friedrich, Zimpel, Carolin, Marquardt, Jens U, Trojan, Jörg, Waidmann, Oliver, Finkelmeier, Fabian

“…The combination of atezolizumab and bevacizumab (A + B) is the new standard of care for the systemic first-line treatment of hepatocellular carcinoma (HCC)…”
Get full text

Helicobacter pylori, gastric cancer and other gastrointestinal malignancies by Venerito, Marino, Vasapolli, Riccardo, Rokkas, Theodore, Delchier, Jean‐Charles, Malfertheiner, Peter

“…In a retrospective study performed in California, U.S.A., ca. 3% of patients with gastric intestinal metaplasia (GIM) developed gastric cancer (GC) within a…”
Get full text

Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg) by Nyssen, Olga P., Perez-Aisa, Angeles, Tepes, Bojan, Castro-Fernandez, Manuel, Kupcinskas, Juozas, Jonaitis, Laimas, Bujanda, Luis, Lucendo, Alfredo, Jurecic, Natasa Brglez, Perez-Lasala, Jorge, Shvets, Oleg, Fadeenko, Galina, Huguet, Jose M., Kikec, Zdenki, Bordin, Dmitry, Voynovan, Irina, Leja, Marcis, Machado, Jose Carlos, Areia, Miguel, Fernandez-Salazar, Luis, Rodrigo, Luis, Alekseenko, Sergey, Barrio, Jesus, Ortuño, Juan, Perona, Monica, Vologzhanina, Liudmila, Romero, Pilar Mata, Zaytsev, Oleg, Rokkas, Theodore, Georgopoulos, Sotirios, Pellicano, Rinaldo, Buzas, Gyorgy M., Modolell, Ines, Gomez Rodriguez, Blas Jose, Simsek, Ilkay, Simsek, Cem, Lafuente, Marina Roldan, Ilchishina, Tatiana, Camarero, Judith Gomez, Dominguez-Cajal, Manuel, Ntouli, Vassiliki, Dekhnich, Natalia Nikolaevna, Phull, Perminder, Nuñez, Oscar, Lerang, Frode, Venerito, Marino, Heluwaert, Frederic, Tonkic, Ante, Caldas, Maria, Puig, Ignasi, Megraud, Francis, O'Morain, Colm, Gisbert, Javier P.

“…The safety of Helicobacter pylori eradication treatments and to what extent adverse events (AEs) influence therapeutic compliance in clinical practice are…”
Get full text

Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience by Müller, Christian, Omari, Jazan, Mohnike, Konrad, Bär, Caroline, Pech, Maciej, Keitel, Verena, Venerito, Marino

“…Patients with unresectable biliary tract cancer (uBTC) who progress despite first-line gemcitabine plus cisplatin (GC) treatment have limited systemic options…”
Get full text

Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs by Vasapolli, Riccardo, Venerito, Marino, Schirrmeister, Wiebke, Thon, Cosima, Weigt, Jochen, Wex, Thomas, Malfertheiner, Peter, Link, Alexander

“…Gastric carcinogenesis is associated with alterations of microRNAs (miRNAs) and reversal of these alterations may be a crucial element in cancer prevention…”
Get full text

Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer by Repetto, Ombretta, De Re, Valli, Giuffrida, Paolo, Lenti, Marco Vincenzo, Magris, Raffaella, Venerito, Marino, Steffan, Agostino, Di Sabatino, Antonio, Cannizzaro, Renato

“…Background Autoimmune atrophic gastritis (AAG) is a chronic disease that can progress to gastric cancer (GC). To better understand AAG pathology, this…”
Get full text

Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward by Franck, Caspar, Müller, Christian, Rosania, Rosa, Croner, Roland S., Pech, Maciej, Venerito, Marino

“…Globally, the death rate of pancreatic ductal adenocarcinoma (PDAC) has doubled over 30 years and is likely to further increase, making PDAC a leading cause of…”
Get full text

Maintenance Therapy with FOLFIRI after FOLFIRINOX for Advanced Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis by Venerito, Marino, Malfertheiner, Peter, Canbay, Ali, Franck, Caspar

“…Objectives. Patients with pancreatic ductal adenocarcinoma (PDA) receiving FOLFIRINOX often develop oxaliplatin-induced polyneuropathy, which limits the…”
Get full text

Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options by Afifi, Ahmed N.A.M., Powerski, Maciej, Jechorek, Dörthe, Brunner, Thomas B., Weigt, Jochen, Venerito, Marino

“…Radiation-induced damage of the upper gastrointestinal (GI) tract results from radiation of GI tumors or structures adjacent to the GI tract. Radiation-induced…”
Get full text

Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC) by Kehmann, Linde, Berres, Marie-Luise, Gonzalez-Carmona, Maria, Modest, Dominik P, Mohr, Raphael, Wree, Alexander, Venerito, Marino, Strassburg, Christian, Keitel, Verena, Trautwein, Christian, Luedde, Tom, Roderburg, Christoph

“…The prognosis of patients with advanced biliary tract cancer (BTC) who have progressed on gemcitabine plus cisplatin is dismal. Trifluridine/tipiracil…”
Get full text

Helicobacter pylori and Gastrointestinal Malignancies by Venerito, Marino, Vasapolli, Riccardo, Rokkas, Theodoros, Malfertheiner, Peter

“…Helicobacter pylori infection is the principal trigger of gastric carcinogenesis and gastric cancer (GC) and remains the third leading cause of cancer‐related…”
Get full text

Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial by Himmelsbach, Vera, Jeschke, Matthias, Lange, Christian M, Scheiner, Bernhard, Pinter, Matthias, Sinner, Friedrich, Venerito, Marino, Queck, Alexander, Trojan, Jörg, Waidmann, Oliver, Finkelmeier, Fabian

“…The tyrosine kinase inhibitors (TKIs) sorafenib and lenvatinib represent the first-line systemic therapy of choice for patients with hepatocellular carcinoma…”
Get full text

Sustained Clinical Response to Ivosidenib in Previously Treated Patients with Advanced Intrahepatic Cholangiocarcinoma Harboring an IDH1 R132 Mutation: Two Case Reports by Müller, Christian, Franke, Sabine, Reisländer, Timo, Keitel, Verena, Venerito, Marino

“…Patients with progressing intrahepatic cholangiocarcinoma (iCCA) harboring an isocitrate dehydrogenase 1 (IDH1) mutation who received ivosidenib showed a…”
Get full text

Gastric Cancer-Epidemiologic and Clinical Aspects by Venerito, Marino, Nardone, Gerardo, Selgrad, Michael, Rokkas, Theodoros, Malfertheiner, Peter

“…Gastric cancer (GC) continues to be an important health threat as the third leading cause of cancer related death in both sexes worldwide. In a recent…”
Get full text